LEVETIRACETAM TEVA ® 250 MG

Ország: Izrael

Nyelv: angol

Forrás: Ministry of Health

Aktív összetevők:

LEVETIRACETAM 250 MG

Beszerezhető a:

TEVA PHARMACEUTICAL INDUST.LTD

ATC-kód:

N03AX14

Gyógyszerészeti forma:

TABLETS

Az alkalmazás módja:

PER OS

Gyártó:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terápiás csoport:

LEVETIRACETAM

Terápiás javallatok:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Engedély dátuma:

2009-09-01